Immuneering Corporation (IMRX)
NasdaqGM - NasdaqGM 即時價格。貨幣為 USD。
加入追蹤清單
收市：04:00PM EDT
收市後：
| 前收市價 | 1.5600 |
| 開市 | 1.7300 |
| 買盤 | 1.6200 x 300 |
| 賣出價 | 1.6500 x 100 |
| 今日波幅 | 1.6000 - 1.7300 |
| 52 週波幅 | 1.3800 - 11.9200 |
| 成交量 | |
| 平均成交量 | 779,210 |
| 市值 | 48.632M |
| Beta 值 (5 年，每月) | -0.89 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -1.8800 |
| 業績公佈日 | 無 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 13.29 |
ZacksImmuneering (IMRX) Plummets 71% in One Week: Here's Why
Immuneering (IMRX) plunges after multiple Wall Street analysts downgraded the stock on lackluster results from an early-stage study evaluating its lead drug across advanced RAS-mutant solid tumors.
InvestorPlace3 Hidden-Gem Biotech Stocks Ready to Ride a Massive Market Wave
The global biotechnology market is a treasure trove of hidden-gem biotech stocks. Valued at $1.55 trillion in 2023, it is anticipated to grow at a CAGR of 13.96% from 2024 to 2030. Government support initiatives aiming to modernize regulatory frameworks, improve approval processes, and standardize clinical studies are key drivers. The rise of personalized medicine and orphan drug formulations are expanding biotechnology applications, attracting innovative companies and boosting market revenue. G
